The Comparison of Awake Fiberoptic And Awake Video Laryngoscopy Tracheal Intubation in Cervical Surgery
NCT ID: NCT03734965
Last Updated: 2021-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2018-08-01
2021-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
METHODS: Patients in the ASA I-II-III risk group, aged 18-80 years, who will undergo cervical surgery operation between 01.04.2018 and 01.04.2020 by the Brain and Neurosurgeon at Trakya University Medical Faculty Hospital will be included. Patients will be prospectively randomized into 2 groups; Group F (intubation with fiberoptic in awake patients), Group V (intubation with videolaringoscopy in awake patients). In successful intubations the time between the time of access to the criterion laryngoscope and the appearance of the vocal cord will be assumed to be 60 seconds. Complications during intubation (mucosal injury, tooth trauma, lip injury, hypoxia (SpO2 \<95%) and esophageal intubation) will be recorded. After intubation, the presence of blood in the Endotracheal Tube (ETT) or sore throat, which is expressed by the patient after recovery, will also be recorded.
STATISTICAL METHODS: Student-T test or Mann Whitney U test will be applied among the groups. Ki-Kara test will be used to compare categorical data.
CONCLUSION: Evaluation of mortality and morbidity of the patients awake intubation with fiberoptic bronchoscopy and videolaryngoscopy for cervical trauma surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AWAKEN INTUBATION FIBEROPTIC
awaken intubation
AWAKEN INTUBATION
Intubation
AWAKEN INTUBATION VIDEOLARYNGOSCOPY
awaken intubation
AWAKEN INTUBATION
Intubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AWAKEN INTUBATION
Intubation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Congenital neurological deficits, those with fiberoptic intubation inconveniences (with cerebrovascular case and hypertension),
* Patients with awake intubation (neuropsychiatric patients with orientation and cooperativeness impairment),
* Cardiovascular patients with local anesthetic allergy,
* Patients with difficult intubation history,
* Cervical surgery,
* Body mass index\> 30 kg / m2,
* Mallampati score III-IV,
* Thyromental distance\> 6 cm,
* Risk of gastric aspiration and pregnancies will be excluded.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Trakya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatih Sag
Principal Investigator; Resident Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sevtap Hekimoglu Sahin, Proffesor
Role: PRINCIPAL_INVESTIGATOR
Trakya University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Trakya University
Edirne, Centrum, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TÜTF-BAEK 2018/90
Identifier Type: -
Identifier Source: org_study_id